oxycodone

(redirected from Oxecta)
Also found in: Dictionary.

oxycodone

 [ok″se-ko´dōn]
an opioid analgesic derived from morphine; used in the form of the hydrochloride and terephthalate salts, administered orally or rectally.

ox·y·co·done

(ok'sē-kō'dōn),
A narcotic analgesic often prepared with aspirin or acetaminophen.

oxycodone

/oxy·co·done/ (-ko´dōn) an opioid analgesic derived from morphine; used in the form of the hydrochloride and terephthalate salts.

oxycodone

(ŏk′sĭ-kō′dōn′)
n.
A semisynthetic opioid drug, C18H21NO4, used in its hydrochloride form as a pain reliever, often in combination with nonopioid analgesics such as acetaminophen.

oxycodone

Hillbilly heroin, poor man's heroin, redneck heroin Pharmacology An oral opioid analgesic, which may be coadministered with other analgesics Pharmacologic effects Morphine-like actions; blocks CNS responses to pain; CNS depressant; analgesic. See Opioids, OxyContin.

ox·y·co·done

(ok'sē-kō'dōn)
A narcotic analgesic often prepared with aspirin or acetaminophen.

oxycodone (ok´sēkō´dōn),

n brand name: Roxicodone; OxyIR; OxyContin;
drug class: synthetic opioid analgesic (Controlled Substance Schedule II);
action: attaches to opiate receptors in the central nervous system;
uses: moderate to severe pain, normally used in combination with aspirin or acetaminophen, the opioid found in Percodan, Percocet, and Tylox. It is an easily abused substance. See also Percocet and Percodan.

oxycodone

a semisynthetic narcotic analgesic derived from morphine.
References in periodicals archive ?
Acura had entered into another letter agreement with Pfizer in Sep 2012, where the latter returned to the former all the products licensed to it under the original license agreement except for Oxecta.
Acura's license grant to Pfizer for the Aversion technology has also been terminated and Acura now owns all rights to Oxecta tablets.
Specialty pharmaceutical company Acura Pharmaceuticals Inc (Nasdaq: ACUR) announced on Monday the expansion of commercialisation of OXECTA (oxycodone HCl) Tablets CII by Pfizer Inc (NYSE: PFE) to health care providers in US in the fourth quarter of 2013.
OXECTA is the reportedly the first immediate-release oxycodone HCl tablet that applies AVERSION technology.
Food and Drug Administration accepted OXECTA which incorporates Acura Pharmaceuticals' proprietary AVERSION technology, in June 2011.
We are pleased to bring OXECTA to patients and physicians with our partner Acura.
We are excited to be partnered with Pfizer to bring OXECTA to patients who need opioids to manage their pain," said Robert Jones, interim president and chief executive officer of Acura Pharmaceuticals, Inc.
OXECTA is covered by US patents issued to Acura and licensed to Pfizer Inc (NYSE:PFE).
24 January 2012 - Acura Pharmaceuticals, Inc (NASDAQ:ACUR) said on Monday it had received information from Pfizer Inc (NYSE:PFE) on the commercial availability of OXECTA (oxycodone HCl, USP) Tablets CII.
Acura Pharmaceuticals Inc (Nasdaq:ACUR), a speciality pharmaceutical company, announced on Monday that it has been informed by Pfizer Inc (NYSE: PFE) that OXECTA (oxycodone HCl, USP) Tablets CII are now commercially available.
M2 PHARMA-October 17, 2011-Pfizer to start commercialisation of OXECTA in US(C)2011 M2 COMMUNICATIONS
M2 EQUITYBITES-July 4, 2011-Acura Pharmaceuticals Inc awarded USD20m milestone payment for FDA's approval of Pfizer Inc's OXECTA used against tampering associated with opioid abuse(C)2011 M2 COMMUNICATIONS http://www.